These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

580 related articles for article (PubMed ID: 14671159)

  • 1. Venous thrombosis and changes of hemostatic variables during cross-sex hormone treatment in transsexual people.
    Toorians AW; Thomassen MC; Zweegman S; Magdeleyns EJ; Tans G; Gooren LJ; Rosing J
    J Clin Endocrinol Metab; 2003 Dec; 88(12):5723-9. PubMed ID: 14671159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of cross-sex hormonal treatment on plasma asymmetric dimethylarginine (ADMA) in healthy male-to-female and female-to-male transsexuals.
    Bunck MC; Giltay EJ; Diamant M; Gooren LJ; Teerlink T
    Atherosclerosis; 2009 Sep; 206(1):245-50. PubMed ID: 19324362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A long-term follow-up study of mortality in transsexuals receiving treatment with cross-sex hormones.
    Asscheman H; Giltay EJ; Megens JA; de Ronde WP; van Trotsenburg MA; Gooren LJ
    Eur J Endocrinol; 2011 Apr; 164(4):635-42. PubMed ID: 21266549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of sex steroids on plasma total homocysteine levels: a study in transsexual males and females.
    Giltay EJ; Hoogeveen EK; Elbers JM; Gooren LJ; Asscheman H; Stehouwer CD
    J Clin Endocrinol Metab; 1998 Feb; 83(2):550-3. PubMed ID: 9467573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of oral and transdermal estrogen replacement therapy on hemostatic variables associated with venous thrombosis: a randomized, placebo-controlled study in postmenopausal women.
    Post MS; Christella M; Thomassen LG; van der Mooren MJ; van Baal WM; Rosing J; Kenemans P; Stehouwer CD
    Arterioscler Thromb Vasc Biol; 2003 Jun; 23(6):1116-21. PubMed ID: 12730085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal of the sex difference in serum leptin levels upon cross-sex hormone administration in transsexuals.
    Elbers JM; Asscheman H; Seidell JC; Frölich M; Meinders AE; Gooren LJ
    J Clin Endocrinol Metab; 1997 Oct; 82(10):3267-70. PubMed ID: 9329351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term treatment of transsexuals with cross-sex hormones: extensive personal experience.
    Gooren LJ; Giltay EJ; Bunck MC
    J Clin Endocrinol Metab; 2008 Jan; 93(1):19-25. PubMed ID: 17986639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mortality and morbidity in transsexual subjects treated with cross-sex hormones.
    van Kesteren PJ; Asscheman H; Megens JA; Gooren LJ
    Clin Endocrinol (Oxf); 1997 Sep; 47(3):337-42. PubMed ID: 9373456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presentation of a meningioma in a transwoman after nine years of cyproterone acetate and estradiol intake: case report and literature review.
    Mancini I; Rotilio A; Coati I; Seracchioli R; Martelli V; Meriggiola MC
    Gynecol Endocrinol; 2018 Jun; 34(6):456-459. PubMed ID: 29105524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormone treatment of the adult transsexual patient.
    Gooren L
    Horm Res; 2005; 64 Suppl 2():31-6. PubMed ID: 16286768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of sex-steroid administration on the pituitary-thyroid axis in transsexuals.
    Bisschop PH; Toorians AW; Endert E; Wiersinga WM; Gooren LJ; Fliers E
    Eur J Endocrinol; 2006 Jul; 155(1):11-6. PubMed ID: 16793944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The sex difference of plasma homovanillic acid is unaffected by cross-sex hormone administration in transsexual subjects.
    Giltay EJ; Kho KH; Blansjaar BA; Verbeek MM; Geurtz PB; Geleijnse JM; Gooren LJ
    J Endocrinol; 2005 Oct; 187(1):109-16. PubMed ID: 16214946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of sex steroid hormones on regional fat depots as assessed by magnetic resonance imaging in transsexuals.
    Elbers JM; Asscheman H; Seidell JC; Gooren LJ
    Am J Physiol; 1999 Feb; 276(2):E317-25. PubMed ID: 9950792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Less effect of intranasal than oral hormone therapy on factors associated with venous thrombosis risk in healthy postmenopausal women.
    Hemelaar M; Rosing J; Kenemans P; Thomassen MC; Braat DD; van der Mooren MJ
    Arterioscler Thromb Vasc Biol; 2006 Jul; 26(7):1660-6. PubMed ID: 16645152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of sex steroids on the neurotransmitter-specific aromatic amino acids phenylalanine, tyrosine, and tryptophan in transsexual subjects.
    Giltay EJ; Bunck MC; Gooren LJ; Zitman FG; Diamant M; Teerlink T
    Neuroendocrinology; 2008; 88(2):103-10. PubMed ID: 18511863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of exogenous oestrogen or (anti-) androgen administration on soluble transferrin receptor in human plasma.
    T'Sjoen GG; Beguin Y; Feyen E; Rubens R; Kaufman JM; Gooren L
    J Endocrinol; 2005 Jul; 186(1):61-7. PubMed ID: 16002536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of oral and transvaginal ethinyl estradiol on hemostatic factors and hepatic proteins in a randomized, crossover study.
    Sitruk-Ware R; Plu-Bureau G; Menard J; Conard J; Kumar S; Thalabard JC; Tokay B; Bouchard P
    J Clin Endocrinol Metab; 2007 Jun; 92(6):2074-9. PubMed ID: 17374706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective randomized trial comparing low dose flutamide, finasteride, ketoconazole, and cyproterone acetate-estrogen regimens in the treatment of hirsutism.
    Venturoli S; Marescalchi O; Colombo FM; Macrelli S; Ravaioli B; Bagnoli A; Paradisi R; Flamigni C
    J Clin Endocrinol Metab; 1999 Apr; 84(4):1304-10. PubMed ID: 10199771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Venous thromboembolism associated with cyproterone acetate in combination with ethinyloestradiol (Dianette): observational studies using the UK General Practice Research Database.
    Seaman HE; de Vries CS; Farmer RD
    Pharmacoepidemiol Drug Saf; 2004 Jul; 13(7):427-36. PubMed ID: 15269926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of Venous Thromboembolism in Transgender Women Receiving Oral Estradiol.
    Arnold JD; Sarkodie EP; Coleman ME; Goldstein DA
    J Sex Med; 2016 Nov; 13(11):1773-1777. PubMed ID: 27671969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.